首页> 外文期刊>Drug Metabolism and Disposition: The Biological Fate of Chemicals >Incubation of whole blood at room temperature does not alter the plasma concentrations of microRNA-16 and -223
【24h】

Incubation of whole blood at room temperature does not alter the plasma concentrations of microRNA-16 and -223

机译:在室温下孵育全血不会改变microRNA-16和-223的血浆浓度

获取原文
获取原文并翻译 | 示例
       

摘要

Plasma-derived microRNAs (miRNAs) are being used as biomarkers, and have been associated with human liver disease and function including fibrosis, inflammation, and drug-induced liver injury. They may also be biomarkers of the drug metabolism function of the liver. In order for plasma miRNA to function as a clinical biomarker, predictable variability is necessary during processing from whole blood to plasma. The current study evaluated the variability of miRNA in whole blood stored for 0.5, 1, 2, 4, 8, and 12 hours following the blood draw under clinical conditions (room temperature) prior to the separation of the plasma. Four healthy volunteers were recruited. Blood from all subjects was collected twice. MicroRNA-16 (miR-16) and miR-223 were evaluated because many studies have shown them to be reliably present in plasma and useful for normalization. miRNA concentrations were measured by real-time polymerase chain reaction. The coefficient of variability of the cycle threshold values for subjects for miR-223 and miR-16 ranged from ~3.6 to 6.8% and ~1.48 to 4.1%, respectively, over the 12-hour incubation. A second blood collection was performed to determine interday variability. The coefficient of variance from the initial blood draw compared with the final blood draw for each subject ranged from 0.42 to 7.9% for miR-16 and 1.7 to 8.3% for miR-223, indicating that these miRNAs have limited interday variability. We conclude that plasma miR-16 or miR-223 concentrations are stable in whole blood at room temperature for up to 12 hours.
机译:血浆来源的microRNA(miRNA)被用作生物标志物,并与人类肝脏疾病和功能相关,包括纤维化,炎症和药物引起的肝损伤。它们也可能是肝脏药物代谢功能的生物标志物。为了使血浆miRNA发挥临床生物标志物的作用,从全血到血浆的处理过程中必须要有可预测的可变性。目前的研究评估了在血浆分离之前在临床条件(室温)下抽血后0.5、1、2、4、8和12小时存储的全血中miRNA的变异性。招募了四名健康志愿者。从所有受试者采集血液两次。之所以对MicroRNA-16(miR-16)和miR-223进行了评估,是因为许多研究表明它们可以可靠地存在于血浆中并且可用于标准化。通过实时聚合酶链反应测量miRNA浓度。在培养12小时后,miR-223和miR-16的受试者的循环阈值变异系数分别为〜3.6至6.8%和〜1.48至4.1%。进行第二次采血以确定日间变化。对于每个受试者,从初始抽血到最终抽血的方差系数对于miR-16为0.42%至7.9%,对于miR-223为1.7%至8.3%,这表明这些miRNA的日间变异性有限。我们得出的结论是,血浆miR-16或miR-223浓度在全血中在室温下稳定长达12小时。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号